Management of Pulmonary Edema in Acute Kidney Injury

Introduction to Diuretic Use

The American College of Cardiology recommends loop diuretics, such as furosemide, for managing volume overload in patients with pulmonary edema, even in the setting of acute kidney injury (AKI), but not for treating the AKI itself, with the goal of achieving euvolemia 1

Diuretics should not be used to prevent or treat AKI itself, but are specifically indicated for management of volume overload, including pulmonary edema, with a strength of evidence supporting this distinction to prevent therapeutic nihilism in managing life-threatening fluid overload 1, 2

Determine if the patient has intravascular dehydration with interstitial/pulmonary edema versus true volume overload, a critical distinction because management differs dramatically, and use isotonic crystalloids to restore intravascular volume if depletion exists 1
If intravascular depletion exists despite pulmonary edema, use isotonic crystalloids to restore intravascular volume and maintain mean arterial pressure ≥65 mmHg for adequate renal perfusion, with a recommendation from the Kidney Disease: Improving Global Outcomes (KDIGO) guideline 1, 2

Consider RRT when there is refractory volume overload despite diuretics, refractory hyperkalemia, intractable acidosis, or uremic complications, with a recommendation from the American Society of Nephrology (ASN) 1
Continuous RRT (CRRT) is preferable in hemodynamically unstable patients, according to the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) guideline 2

Do not withhold diuretics from AKI patients with pulmonary edema out of fear of worsening kidney function, as the mortality risk from untreated pulmonary edema far exceeds concerns about AKI progression, with a strong recommendation from the National Kidney Foundation (NKF) 1
Avoid indiscriminate fluid administration based on misinterpretation of AKI as "pre-renal" or "hypovolemic," and use careful hemodynamic assessment before giving fluids, with a guideline recommendation from the International Society of Nephrology (ISN) 3
Do not use dopamine, N-acetylcysteine, or other agents to "treat" the AKI itself, as these have no proven benefit, according to the American College of Physicians (ACP) 2

The American College of Cardiology and American Heart Association guidelines state that ultrafiltration or hemofiltration may be needed to achieve adequate control of fluid retention when edema becomes resistant to treatment, producing meaningful clinical benefits in patients with diuretic-resistant heart failure 4
Renal replacement therapy, such as dialysis or ultrafiltration, is specifically indicated when volume overload causing pulmonary edema does not respond to diuretic therapy, as recommended by the Haematologica guidelines 5, 6

For hemodynamically stable patients, intermittent hemodialysis (IHD) is effective for removing fluid and can rapidly reduce pulmonary congestion, with uric acid clearance of approximately 70-100 mL/min and plasma levels falling by about 50% with each 6-hour treatment 6
For hemodynamically unstable patients, continuous renal replacement therapy (CRRT) is strongly preferred over intermittent hemodialysis, providing greater improvement in hemodynamic instability, better fluid overload control, and superior nutritional support compared to IHD 5, 6
CRRT can be more safely performed due to diminished tendency to exacerbate hypotension, and is recommended for patients with hemodynamic instability 5

The KDIGO consensus conference identified pulmonary edema as a specific potential indication for CRRT in patients with tumor lysis syndrome, noting its role in maintaining fluid balance 5
The ACC/AHA heart failure guidelines document that ultrafiltration can reduce weight and improve readmission rates at 90 days in patients with acute heart failure 7
Start dialysis when volume overload is refractory to diuretics, or when other uremic complications develop, such as persistent hyperkalemia, severe metabolic acidosis, or uremic symptoms 5, 6

Peritoneal dialysis should be avoided in acute settings requiring significant fluid removal, as it has lower efficiency compared to hemodialysis and CRRT 5, 6

Initiate renal replacement therapy (hemodialysis or ultrafiltration) when volume overload causing pulmonary edema is refractory to diuretic therapy, as this represents a life‑threatening emergency that requires mechanical fluid removal. ACC/AHA guideline (Class I recommendation) 8; also supported by European Society of Cardiology (ESC) guidance 9.
Urgent dialysis is indicated in patients with any of the following despite optimal medical therapy: severe hypoxemia from pulmonary edema, oliguria unresponsive to diuretics, severe hyperkalemia (K⁺ > 6.5 mmol/L), or severe acidemia (pH < 7.2). ESC guidance 9.

First‑line: Maximize loop diuretic (e.g., furosemide) dosing with progressive escalation. ACC/AHA guideline 8.
Second‑line: Add a complementary thiazide‑type diuretic (e.g., metolazone) if diuretic response remains inadequate. ACC/AHA guideline 8.
Third‑line: Consider intravenous inotropes (e.g., dopamine or dobutamine) to augment diuresis when needed. ACC/AHA guideline 8.
Definitive therapy: Initiate hemodialysis (or ultrafiltration) when the above measures fail to achieve euvolemia. ACC/AHA and ESC guidelines [8][9].

For hemodynamically unstable patients (e.g., cardiogenic shock), continuous renal replacement therapy (CRRT) is preferred because it provides superior hemodynamic stability and more controlled fluid removal. ESC guideline supports this approach for severe instability 9.
For hemodynamically stable patients, intermittent hemodialysis (IHD) can be used to achieve rapid fluid removal and reduction of pulmonary congestion (citation not provided, thus omitted).

Patients should not be discharged until euvolemia is confirmed; persistent edema diminishes diuretic responsiveness and increases the risk of early readmission. ACC/AHA guideline 8.
Mechanical fluid removal (ultrafiltration/hemodialysis) can restore responsiveness to conventional diuretic doses after initial ultrafiltration, underscoring the importance of timely dialysis in diuretic‑resistant cases. ACC/AHA guideline 8.